NEW YORK - OSI Pharmaceuticals Inc. said today that it is suing Teva Pharmaceutical Industries Ltd. and Mylan Inc. for patent infringement, as the companies are seeking to market a generic version of OSI's daily cancer pill Tarceva.
Trending
